The draft guidance outlines the design of clinical trials in order to reduce clinical uncertainty and improve data available at the time of approval, according to a March 24 FDA release. Two ...

Sept 3 (Reuters) - The U.S. Food and Drug Administration on Wednesday proposed a new process to streamline the approval of drugs targeting rare diseases with very small patient populations, including ...